Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017 Year: 2017
Multidrug resistant tuberculosis (MDR-TB) and tobacco smoking: clinical and experimental investigation Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
The effect of the tobacco smoke condensate (TSC) on the structural changes in Mycobacterium tuberculosis (MTB) Source: Annual Congress 2005 - Passive smoking and passive doctors Year: 2005
The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004
Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study Source: Eur Respir J, 56 (3) 1901875; 10.1183/13993003.01875-2019 Year: 2020
Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis : contribution of murine studies Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020 Year: 2021
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB Source: Eur Respir J, 57 (1) 2001796; 10.1183/13993003.01796-2020 Year: 2021
Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis Source: Eur Respir J , 49 (4) 1602215; DOI: 10.1183/13993003.02215-2016 Year: 2017
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB Source: Eur Respir Mon 2012; 58: 1-13 Year: 2012
Method of evaluation of tuberculocidal effectiveness of disinfectants in clinical strains of Mycobacterium tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010
Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
The main clinical problem of increasing resistance of Mycobacterium tuberculosis (MT) to first-line anti-TB drugs Source: Eur Respir J 2005; 26: Suppl. 49, 654s Year: 2005
Results of multicentral external quality assessment for M. tuberculosis drug susceptibility testing in Russia Source: Eur Respir J 2005; 26: Suppl. 49, 646s Year: 2005